Dynamic panel-data estimation, two-step robust system GMM
| Variables | ROA (model 1) | ROE (model 2) | EPS (model 3) | TOB (model 4) |
|---|---|---|---|---|
| Lag of ROA, ROE, EPS, TOB | −0.023 *** | 0.207 *** | 0.203 *** | 0.331 *** |
| (0.004) | (0.010) | (0.006) | (0.003) | |
| Equity multiplier | 0.064 *** | 0.197 *** | 0.404 *** | 0.101 |
| (0.011) | (0.027) | (0.028) | (0.567) | |
| Interest coverage | 0.027 *** | 0.083 *** | 0.889 *** | 0.320 *** |
| (0.007) | (0.004) | (0.037) | (0.116) | |
| Fixed charge coverage ratio | 0.085 *** | 0.337 *** | 0.660 *** | −0.300 *** |
| (0.003) | (0.067) | (0.078) | (0.104) | |
| Degree of financial leverage | −0.046 | −0.431 *** | −0.759 *** | 0.772 *** |
| (0.030) | (0.051) | (0.054) | (0.110) | |
| Debt to EBITDA | 0.158 *** | −0.029 *** | −0.120 *** | −0.285 *** |
| (0.008) | (0.012) | (0.019) | (0.103) | |
| Capitalization ratio | −0.366 *** | −0.131 *** | −0.256 *** | −0.286 *** |
| (0.011) | (0.024) | (0.021) | (0.010) | |
| Age | 0.023 *** | 0.161 *** | 0.967 *** | −0.146 *** |
| (0.016) | (0.020) | (0.219) | (0.067) | |
| Sales growth | 0.064 *** | 0.173 *** | 0.216 *** | 0.198 *** |
| (0.004) | (0.006) | (0.007) | (0.016) | |
| Size of firm | −0.027 *** | −0.126 *** | 0.335 | 0.372 *** |
| (0.006) | (0.008) | (1.128) | (0.137) | |
| Number of observations | 4,900 | 4,974 | 4,875 | 4,974 |
| No. of instruments | 185 | 197 | 178 | 222 |
| No. of group | 263 | 263 | 263 | 263 |
| Arellano–Bond: AR (1) | 0.043 | 0.006 | 0.030 | 0.000 |
| Arellano–Bond: AR (2) | 0.812 | 0.456 | 0.334 | 0.564 |
| Sargan test (p-value) | 0.346 | 0.761 | 0.653 | 0.228 |
| Hansen test (p-value) | 0.234 | 0.112 | 0.265 | 0.123 |
| Variables | ROA (model 1) | ROE (model 2) | EPS (model 3) | TOB (model 4) |
|---|---|---|---|---|
| Lag of ROA, ROE, EPS, TOB | −0.023 *** | 0.207 *** | 0.203 *** | 0.331 *** |
| (0.004) | (0.010) | (0.006) | (0.003) | |
| Equity multiplier | 0.064 *** | 0.197 *** | 0.404 *** | 0.101 |
| (0.011) | (0.027) | (0.028) | (0.567) | |
| Interest coverage | 0.027 *** | 0.083 *** | 0.889 *** | 0.320 *** |
| (0.007) | (0.004) | (0.037) | (0.116) | |
| Fixed charge coverage ratio | 0.085 *** | 0.337 *** | 0.660 *** | −0.300 *** |
| (0.003) | (0.067) | (0.078) | (0.104) | |
| Degree of financial leverage | −0.046 | −0.431 *** | −0.759 *** | 0.772 *** |
| (0.030) | (0.051) | (0.054) | (0.110) | |
| Debt to EBITDA | 0.158 *** | −0.029 *** | −0.120 *** | −0.285 *** |
| (0.008) | (0.012) | (0.019) | (0.103) | |
| Capitalization ratio | −0.366 *** | −0.131 *** | −0.256 *** | −0.286 *** |
| (0.011) | (0.024) | (0.021) | (0.010) | |
| Age | 0.023 *** | 0.161 *** | 0.967 *** | −0.146 *** |
| (0.016) | (0.020) | (0.219) | (0.067) | |
| Sales growth | 0.064 *** | 0.173 *** | 0.216 *** | 0.198 *** |
| (0.004) | (0.006) | (0.007) | (0.016) | |
| Size of firm | −0.027 *** | −0.126 *** | 0.335 | 0.372 *** |
| (0.006) | (0.008) | (1.128) | (0.137) | |
| Number of observations | 4,900 | 4,974 | 4,875 | 4,974 |
| No. of instruments | 185 | 197 | 178 | 222 |
| No. of group | 263 | 263 | 263 | 263 |
| Arellano–Bond: AR (1) | 0.043 | 0.006 | 0.030 | 0.000 |
| Arellano–Bond: AR (2) | 0.812 | 0.456 | 0.334 | 0.564 |
| Sargan test ( | 0.346 | 0.761 | 0.653 | 0.228 |
| Hansen test ( | 0.234 | 0.112 | 0.265 | 0.123 |
Source(s): Authors’ own work
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.